Skip to content

Drug interactions

Cannabidiol + Repaglinide

Severity: Moderate

Cannabidiol and Repaglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cannabidiol may inhibit CYP2C8, a major pathway for repaglinide metabolism, raising repaglinide exposure. This could increase the risk of hypoglycemia.

What this interaction means in plain words

Cannabidiol and Repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cannabidiol belongs to Central Nervous System; Repaglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of CYP2C8-mediated metabolism of repaglinide.

What to do

Monitor blood glucose when cannabidiol is started or stopped and reduce the repaglinide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cannabidiol and Repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cannabidiol with Repaglinide?

MediHelp rates the interaction as moderate. Cannabidiol and Repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cannabidiol may inhibit CYP2C8, a major pathway for repaglinide metabolism, raising repaglinide exposure. This could increase the risk of hypoglycemia.

How serious is the interaction between Cannabidiol and Repaglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when cannabidiol is started or stopped and reduce the repaglinide dose if hypoglycemia occurs.

What other medicines interact with Repaglinide?

MediHelp also lists interactions of Repaglinide with, for example, Gemfibrozil, Clarithromycin, Clopidogrel. The full list is on the Repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in